2nd MULTI-STAKEHOLDER MEETING – Ensuring patient centricity in Osteogenesis Imperfecta research
13 June 2024 @ 8:30 am - 5:40 pm
REMEDi4ALL is hosting our 2nd Multi-stakeholder Meeting (MS) – Ensuring patient centricity in Osteogenesis Imperfecta (OI) research.
Join the MSM
REMEDi4ALL invites all stakeholders in the OI research community to join us for a day of learning, discussion, and inspiration.
We welcome clinicians, academics, patients and patient representatives, pharmaceutical companies, regulators, payers, health economists and all interested in OI and Rare Bone Diseases research. Together, we will discuss and develop patient centric approaches to research and medicines development for OI.
Our MSM will:
- Share information and advance learning, in a pre-competitive and cooperative setting
- Develop constructive dialogue between all stakeholders
- Facilitate collaboration and knowledge exchange
- Identify current hurdles and propose solutions to ensure patient centricity in OI research
- Publish and disseminate the meeting outcomes to a broader community
The Power of Patients
The patient’s voice is at the heart of this meeting. The OI community and the REMEDi4ALL Patient Advocacy Group have played integral roles in shaping the content and format of this event.
We wanted to ensure that the patients’ perspectives, experiences, and preferences guide our discussions and are at the forefront of OI research and therapeutic development. Over the day, you will hear from numerous patients, patients representative and advocates. They will:
- Share their personal journeys of living with OI, providing insights into the day-to-day challenges they face, as well as the triumphs and setbacks they encounter.
- Highlight unmet medical needs within the OI community
- Discuss patient-relevant research questions and identify research priorities
Patients will have the opportunities to
- Learn about the recent advancements in medicines development in OI
- Initiate collaborations and partnerships with all stakeholders
- Actively participate and engage in scientific discussions about OI
Patient centricity will run as a core-narrative in all our sessions and panel discussions, encouraging each stakeholder to consider the patient perspective in their current and future work.
Agenda (might be subject to change)
WEDNESDAY, 12 JUNE 2024
| 19.30/20.00 | Arrival and Speakers Dinner at the Hotel | BY INVITATION ONLY |
THURSDAY, 13 JUNE 2024 (8.30 – 17.40 CEST)
| 8.30 – 8.45 | Registration | |
| 8.45 – 8.50 | Opening Ceremony and Welcome | Claudia Fuchs (EURORDIS)
Leonardo Panzeri (AS.IT.O.I.) |
SESSION 1: Multi-national strategies for Patient Advocacy in OI
Moderators: Claudia Fuchs & Eve Hewitt
| 8.50 – 9.10 | Opening Speech by a Patient: What does it mean living with OI? | Gem Turner |
| 9.10 – 9.25 | The European Reference Network on rare bone diseases (ERN-Bond) | Luca Sangiorgi (Istituto Ortopedico Rizzoli) |
| 9.25 – 9.45 | The European Registries for Rare Bone and Mineral Conditions (EuRR-Bone) | Claudia Finis (DOIG (German Ostogenesis Imperfecta Organisation and Berlin Institute of Health at Charité) |
| 9.45 – 10.05 | Patient Engagement Initiatives in Rare Diseases: an Italian Perspective | Annalisa Scopinaro (UNIAMO – Federazione Italiana Malattie Rare) |
| Lightening talks: European and National Patient Engagement Activities in OI | ||
| 10.05 – 10.15 | Stronger Together: OIFE’s Patient Engagement Initiatives | Anna Rossi (OIFE) |
| 10.15 – 10.25 | Introduction to Patient Engagement Activities in Italy | Simona Paveri (AS.IT.O.I.) |
| 10.25 – 10.35 | Introduction to Patient Engagement Activities in Norway | Inger-Margrethe Stavdal Paulsen (Norsk Forening for Osteogenesis Imperfecta) |
| 10.35 – 10.45 | Introduction to Patient Engagement Activities in Spain | Miguel Rodríguez Molina (Asociación Nacional Huesos de Cristal OI España – AHUCE) |
| 10.45 – 10.55 | Brittle Bone Society – Support that matters most | Patricia Osborne (Brittle Bone Society – BBS) |
| 10.55 – 11.05 | Q/A session | |
| 11.05 – 11.30 | Coffee Break | |
SESSION 2: Current Treatment Options in OI – a multistakeholder perspective
Moderators: Anna Rossi & Luca Sangiorgi
| 11.30 – 11.50 | Introduction to different treatment options and approaches for OI | Nick Bishop (The University of Sheffield) |
| 11.50 – 12.10 | Introduction to the REMEDi4ALL MOI-A Study | Judith Cohen (University of Hull) |
| Lightening talks: Current ongoing clinical trials with specific focus on challenges and opportunities of Patient Engagement | ||
| 12.10 – 12.20 | TOPaZ trial | Stuart Ralson (University of Edinburgh) |
| 12.20 – 12.30 | The ORBIT Phase II/III trial, a collaborative design to study setrusumab treatment effect in OI | Luigi Picaro (Mereo BioPharma) |
| 12.30 – 12.40 | BOOSTB4 Trial: Boost Brittle Bones Before Birth | Cecilia Götherström (Karolinska Institute) |
| 12.40 – 12.50 | Q/A session | |
| 12.50 – 14.00 | Lunch Break | |
SESSION 3: “Patient-centered clinical trial design”
Moderators: Nick Bishop & Claudia Fuchs
| Lightening talks: Patient perception and experience in clinical trials | ||
| 14.00 – 14.05 | Patient Perspective as a Teenager | Emilija and Dace Liepina |
| 14.05 – 14.10 | Patient Experience on the ASTEROID Trial | Marie Holm Laursen |
| 14.10 – 14.15 | Patient Engagement activites within the R4ALL demonstrator (MOI-A Study) | Marina O’Callaghan |
| 14.15 – 14.25 | Q/A session | |
| Lightening talks: Presentation of different inititatives in OI | ||
| 14.25 –14.35 | The Impact Survey Initiative | Oliver Semler (University of Cologne) |
| 14.35 – 14.45 | Adult Health Initiative | Stuart Ralson (University of Edinburgh) |
| 14.45 – 14.55 | Care4BrittleBones Initiative Key4OI | Lida Zhytnik (Amsterdam UMC) |
| 14.55 – 15.05 | Q/A session | |
| Lightening talks: Quality of Life assessment (QoL) and patient related innovative outcome measures in clinical trials in OI | ||
| 15.05 – 15.15 | QoL assessment in OI | Nick Bishop (The University of Sheffield) |
| 15.15 – 15.25 | Developing patient related outcome measures in clinical trials for rare bone disorders | TBC |
| 15.25 – 15.35 | Developing patient related outcome measures on mobility in rare bone disorders | Luca Sangiorgi (Istituto Ortopedico Rizzoli) |
| 15.35 – 15.50 | Regulatory perspective on innovative outcome measures – how can patients contribute? | Violeta Stoyanova-Beninska (Committee for Orphan Medicinal Products) |
| 15.50 – 16.00 | Patient perspective on innovative outcome measure – how to advocate? | Inger-Margrethe Stavdal Paulsen (Norsk Forening for Osteogenesis Imperfecta) |
| 16.00 – 16.20 | Coffee Break | |
PANEL DISCUSSIONS
| 16.20 – 16.50 | Panel discussion on innovative outcome measures in clinical trials | Moderators: Inger-Margrethe Stavdal Paulsen & Eve Hewitt
Panelists to be announced |
| 16.50 – 17.20 | (Panel discussion) Ask the experts: how to become a patient advocate in OI? | Moderators: Marina O’Callaghan – Claudia Fuchs
Panelists to be announced |
| 17.20 – 17.30 | Wrap Up of the Panel Discussions | Claudia Fuchs – Eve Hewitt |
| 17.30 – 17.40 | Patient engagement in early Health Technology Assessment (HTA) | Zsuzsanna Petyko (Syreon) |
GET TOGETHER
| 19.30/20.00 | Speakers Dinner in the Center of Bologna | BY INVITATION ONLY |
FRIDAY, 14 JUNE 2024
9.00 – 11.00 CEST
| 9.00 – 11.00 | Workshop on early HTA assessment | BY INVITATION ONLY |
Download the event flier here.
Speakers
Click here to see the complete list of speakers and their bios.
Confirmed speakers:
Organisers
Organised within the REMEDi4ALL project in collaboration with EURORDIS – Rare Disease Europe, Beacon for Rare Diseases, Associazione Italiana Osteogenesi Imperfetta – AS.IT.O.I., Osteogenesis Imperfecta Federation Europe – OIFE, European Reference Network on rare bone diseases – ERN BOND.
Registration
This event will be a hybrid event, hosted both online and in-person (Bologna, Italy).
Register here
